StonvexLoading…
StonvexStonvexStonvexCore line items from FPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $108.16M | $235.98M | $209.85M | $41.03M |
Operating Income | $212.46M | $205.10M | $109.30M | $-36.24M |
Net Income | $70.97M | $68.30M | $55.39M | $-15.40M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $3.25B | $3.08B | $2.97B | $2.89B |
Total Liabilities | $860.41M | $896.32M | $962.18M | $992.74M |
Cash & Equivalents | $425.55M | $430.88M | $353.80M | $131.77M |
Free Cash Flow OCF − CapEx | $105.01M | $115.18M | $154.10M | $-188.38M |
Shares Outstanding | Not available | Not available | Not available | Not available |